Insider trading

Period: 120 months Stock: ENTA Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

18 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

18 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

18 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

18 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
18 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
18 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

18 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Dec 2025
Luly Jay R. President and CEO
Sold at will
$67.49K 4,743 at 14.23
0.5%
Not planned
5 Dec 2025
Or Yat Sun Chief Scientific Officer
Sold at will
$34.01K 2,390 at 14.23
0.6%
Not planned
5 Dec 2025
Kieffer Tara Lynn Chief Product Strategy Officer
Sold at will
$29.97K 2,106 at 14.23
6.4%
Not planned
5 Dec 2025
Luu Brendan Chief Business Officer
Sold at will
$19.84K 1,394 at 14.23
3.5%
Not planned
5 Dec 2025
Rottinghaus Scott T. Chief Medical Officer
Sold at will
$11.36K 798 at 14.23
3.5%
Not planned
5 Dec 2025
Trout Harry R. III See Remarks
Sold at will
$7.71K 542 at 14.23
3.2%
Not planned
5 Dec 2025
Capps Kathleen S. See Remarks
Sold at will
$4.60K 323 at 14.23
3.7%
Not planned
2 Dec 2025
Trout Harry R. III See Remarks
Sold at will
$5.30K 380 at 13.96
2.2%
Not planned
2 Dec 2025
Capps Kathleen S. See Remarks
Sold at will
$2.89K 207 at 13.96
2.3%
Not planned
12 Feb 2025
Luly Jay R. President and CEO
Bought
$256.05K 45,000 at 5.69
5.6%
First buy on file
13 Dec 2023
Vance Terry Director
Sold at will
$139.49K 15,295 at 9.12
72.5%
Sold half or more
5 Dec 2023
Luly Jay R. President and CEO
Sold at will
$69.62K 7,230 at 9.63
0.9%
Not planned
5 Dec 2023
MELLETT PAUL J Sr. VP, Finance & Admin. & CFO
Sold at will
$23.23K 2,412 at 9.63
2.5%
Not planned
5 Dec 2023
Or Yat Sun Sr. VP, R&D & CSO
Sold at will
$23.23K 2,412 at 9.63
0.6%
Not planned
5 Dec 2023
Gardiner Nathaniel S. Sr. VP & General Counsel
Sold at will
$23.23K 2,412 at 9.63
3.4%
Not planned
5 Dec 2023
Luu Brendan Sr. VP, Business Dev.
Sold at will
$20.46K 2,125 at 9.63
5.5%
Not planned
5 Dec 2023
Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev
Sold at will
$20.46K 2,125 at 9.63
5.4%
Not planned
5 Dec 2023
Rottinghaus Scott T. Sr. VP & CMO
Sold at will
$5.14K 534 at 9.63
2.0%
Not planned
Showing 1–18 of 18.